SCHEMBL31436060

SCHEMBL31436060

CC(C)(C)OC(=O)NCCCNc1nc(NCCCNC(=O)OC(C)(C)C)nc(NCCCNC(=O)OC(C)(C)C)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STK17B O94768 1/20 0.58
▸ STK17A Q9UEE5 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.56
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ GAA P10253 1/20 0.53
▸ ADORA2A P29274 2/20 0.50
▸ ADORA1 P30542 2/20 0.50
▸ ADORA2B P29275 1/20 0.50
▸ MAOA P21397 1/20 0.49
▸ MAOB P27338 1/20 0.49
▸ BRD4 O60885 5/20 0.47
▸ CA12 O43570 4/20 0.47
▸ CA1 P00915 4/20 0.47
▸ CA2 P00918 4/20 0.47
▸ CA9 Q16790 4/20 0.47
▸ HTT P42858 1/20 0.46
▸ BCHE P06276 1/20 0.45
▸ LMNA P02545 1/20 0.43
▸ TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31436112 0.94 TDP1 (0.62) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL31436080 0.94 TDP1 (0.58) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL31436059 0.93 STK17B (0.62) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL31436071 0.93 TDP1 (0.69) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL16134193 0.91 STK17B (0.51) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL31436103 0.90 STK17B (0.50) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL31436097 0.90 STK17B (0.50) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL17564533 0.90 STK17B (0.62) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL31436057 0.88 STK17B (0.48) STK17BSTK17ATDP1MEN1KMT2A
SCHEMBL23543324 0.87 STK17B (0.47) STK17BSTK17ATDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025088570-A1 IONIZABLE LIPIDS AND IONIZABLE LIPID NANOPARTICLES CRISPR THERAPEUTICS AG (CH) 2025-05-01 — — WO disclosed
Send feedback